This paper is in the following e-collection/theme issue:

Proposals (non-eHealth) (47)

Published on in Vol 8, No 10 (2019): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13696, first published .
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

Authors of this article:

Laura Beaton1 Author Orcid Image ;   Henry F J Tregidgo2 Author Orcid Image ;   Sami A Znati1 Author Orcid Image ;   Sharon Forsyth3 Author Orcid Image ;   Matthew J Clarkson2 Author Orcid Image ;   Steven Bandula4 Author Orcid Image ;   Manil Chouhan4 Author Orcid Image ;   Helen L Lowe5 Author Orcid Image ;   May Zaw Thin6 Author Orcid Image ;   Julian Hague7 Author Orcid Image ;   Dinesh Sharma8 Author Orcid Image ;   Joerg-Matthias Pollok9, 10 Author Orcid Image ;   Brian R Davidson9, 10 Author Orcid Image ;   Jowad Raja7 Author Orcid Image ;   Graham Munneke7 Author Orcid Image ;   Daniel J Stuckey6 Author Orcid Image ;   Zainab A Bascal11 Author Orcid Image ;   Paul E Wilde11 Author Orcid Image ;   Sarah Cooper11 Author Orcid Image ;   Samantha Ryan11 Author Orcid Image ;   Peter Czuczman11 Author Orcid Image ;   Eveline Boucher11 Author Orcid Image ;   John A Hartley1 Author Orcid Image ;   Andrew L Lewis11 Author Orcid Image ;   Marnix Jansen1 Author Orcid Image ;   Tim Meyer1, 12 Author Orcid Image ;   Ricky A Sharma13 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics

Journals

  1. Mikhail A, Negussie A, Mauda-Havakuk M, Owen J, Pritchard W, Lewis A, Wood B. Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications. Expert Opinion on Drug Delivery 2021;18(3):383 View
  2. Hagan A, Znati S, Carter R, Westhorpe A, Macfarlane W, Phillips G, Lloyd A, Sharma R, Lewis A. Vandetanib-eluting radiopaque beads for chemoembolization: physicochemical evaluation and biological activity of vandetanib in hypoxia. Anti-Cancer Drugs 2021;32(9):897 View
  3. Beaton L, Tregidgo H, Znati S, Forsyth S, Counsell N, Clarkson M, Bandula S, Chouhan M, Lowe H, Thin M, Hague J, Sharma D, Pollok J, Davidson B, Raja J, Munneke G, Stuckey D, Bascal Z, Wilde P, Cooper S, Ryan S, Czuczman P, Boucher E, Hartley J, Atkinson D, Lewis A, Jansen M, Meyer T, Sharma R. Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies. Journal of Vascular and Interventional Radiology 2022;33(9):1034 View
  4. Beaton L, Daly M, Tregidgo H, Grimes H, Moinuddin S, Stacey C, Znati S, Hague J, Bascal Z, Wilde P, Cooper S, Bandula S, Lewis A, Clarkson M, Sharma R. Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy. The British Journal of Radiology 2022;95(1130) View